4//SEC Filing
Deardorf Caren 4
Accession 0001209191-23-038823
CIK 0001658247other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:00 PM ET
Size
7.6 KB
Accession
0001209191-23-038823
Insider Transaction Report
Form 4
Deardorf Caren
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-16+17,500→ 17,500 totalExercise: $20.32Exp: 2033-06-15→ Common Stock (17,500 underlying) - Award
Common Stock
2023-06-16+6,000→ 6,000 total
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- [F2]The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001871152
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:00 PM ET
- Size
- 7.6 KB